Roswell Park Cancer Institue's James Mohler, MD, on the risks of PSA screening
Cancer Deaths are Decreasing, but New Cases are Expected to Reach Peak in 2024
Over 4 million cancer deaths have been reverted since 1991, but new cancer cases are estimated to reach over 2 million, according to new data from an annual American Cancer Society report.
Patient Goals Should Figure Prominently in Tx Discussions
Wanted: Physicians who will interact with patients the way a good financial counselor would.
Prostate Cancer Treatments Abundant, Not Perfect
A range of options for metastatic castration resistant prostate cancer offer benefits, but impact on survival and sequencing guidance are less than optimal.
No Added Prostate Cancer Risk With Long-term Testosterone Tx
Risk does not go up with exposure to testosterone therapy over a 5-year period or according to total testosterone injections.
Safest for Favorable-risk Prostate Cancer: Surveillance
The goal is to avoid treating men who don’t need surgery or radiation. A new long-term study points to the potential of surveillance as a treatment option.
Paradox: Asthma Resists Lethal Prostate Cancer
Lethal prostate cancer is less-not more-likely to develop in patients with asthma. The Health Professionals Follow-up Study answers key questions about why.